| Literature DB >> 2545451 |
I D Mutz1, F Krainer, J Deutsch, C Kunz, D E Teuwen.
Abstract
In a double blind placebo-controlled study rotavirus vaccine RIT 4237 was offered to young infants after the fourth week of life. The vaccine was very well tolerated. Fifty-seven out of 100 vaccine recipients and 10 out of 103 placebo recipients developed rotavirus-IgM-antibodies during the 1 month follow-up period. During a 6 month follow-up, stool samples from 2 out of 12 vaccinees and from 5 out of 12 placebo recipients contained rotavirus.Entities:
Mesh：
Substances：
Year: 1989 PMID： 2545451 DOI： 10.1007/BF00441518
Source DB: PubMed Journal: Eur J Pediatr ISSN： 0340-6199 Impact factor: 3.183